{"title":"GABARAN治疗后急性胰腺炎","authors":"M. Stoicescu","doi":"10.4172/2329-6631.1000146","DOIUrl":null,"url":null,"abstract":"The main objective of this clinical-case-presentation is to attract attention that the therapy with Gabaran in high dosage and per long period of time without a careful control of function of pancreas (common dosage of amilasemia and amilasuria level) can develop unexpected severe acute pancreatitis and may put the patient’s life in danger.","PeriodicalId":15589,"journal":{"name":"Journal of Developing Drugs","volume":"18 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2015-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Acute Pancreatitis after Therapy with GABARAN\",\"authors\":\"M. Stoicescu\",\"doi\":\"10.4172/2329-6631.1000146\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The main objective of this clinical-case-presentation is to attract attention that the therapy with Gabaran in high dosage and per long period of time without a careful control of function of pancreas (common dosage of amilasemia and amilasuria level) can develop unexpected severe acute pancreatitis and may put the patient’s life in danger.\",\"PeriodicalId\":15589,\"journal\":{\"name\":\"Journal of Developing Drugs\",\"volume\":\"18 1\",\"pages\":\"1-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-12-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Developing Drugs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2329-6631.1000146\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Developing Drugs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2329-6631.1000146","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The main objective of this clinical-case-presentation is to attract attention that the therapy with Gabaran in high dosage and per long period of time without a careful control of function of pancreas (common dosage of amilasemia and amilasuria level) can develop unexpected severe acute pancreatitis and may put the patient’s life in danger.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
